| 1 | Study | 1.96% | |
| 2 | Pediatric | 1.31% | |
| 3 | Lymphoma | 1.31% | |
| 4 | SA | 1.31% | |
| 5 | Pivotal | 0.65% | |
| 6 | Control | 0.65% | |
| 7 | Reduced | 0.65% | |
| 8 | Offers | 0.65% | |
| 9 | Factors | 0.65% | |
| 10 | Titers | 0.65% | |
| 11 | Caused | 0.65% | |
| 12 | Gut | 0.65% | |
| 13 | Central | 0.65% | |
| 14 | Speckle-Tracking | 0.65% | |
| 15 | Pump | 0.65% | |
| 16 | Resistance | 0.65% | |
| 17 | Nerve | 0.65% | |
| 18 | Detection | 0.65% | |
| 19 | Antibody | 0.65% | |
| 20 | Indicator | 0.65% | |
| 21 | Inhibitor | 0.65% | |
| 22 | Rapid | 0.65% | |
| 23 | Randomized | 0.65% | |
| 24 | Liquid | 0.65% | |
| 25 | Sobi | 0.65% | |
| 26 | Could | 0.65% | |
| 27 | Overlap | 0.65% | |
| 28 | Complexity | 0.65% | |
| 29 | Part | 0.65% | |
| 30 | Energy | 0.65% | |
| 31 | Comorbidities | 0.65% | |
| 32 | Therapy | 0.65% | |
| 33 | Caudal | 0.65% | |
| 34 | Controlled | 0.65% | |
| 35 | Elderly | 0.65% | |
| 36 | Antimuscarinic | 0.65% | |
| 37 | Multiple | 0.65% | |
| 38 | FFMI | 0.65% | |
| 39 | Multimodal | 0.65% | |
| 40 | Fracture | 0.65% | |
| 41 | Patients | 0.65% | |
| 42 | Exploratory | 0.65% | |
| 43 | Ultra-Sensitive | 0.65% | |
| 44 | Targeting | 0.65% | |
| 45 | Diabetes | 0.65% | |
| 46 | Antibiotics | 0.65% | |
| 47 | Assay | 0.65% | |
| 48 | Metabolites | 0.65% | |
| 49 | Recognizing | 0.65% | |
| 50 | Acetylcholine | 0.65% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||